Clinical Trial Update: Optimizing Cytokine-Induced Killer Cells in Glioblastoma Patients

View source ↗

Summary

A clinical trial registry entry describing optimization of cytokine-induced killer cells for glioblastoma, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Cytokine-induced killer cells

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Glioblastoma, Cytokine-Induced Killer Cells | Status: NOT_YET_RECRUITING